8 results
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
Lisinopril - ACE ... inhibitor used for the treatment ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor #Overview ... #Review
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... for inclusion all ... updated systematic review ... EBM #Management #Pharmacology ... Personality #Disorder #Medications
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
(PRES) Overview ... circulation: MCA ACA ... Electrolyte abnormality, Medication ... /Drug toxicity, ... epilepticus Treatment
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome ... Inhibitors of Na+K+2Cl ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Chloramphenicol - Antibiotics Class Overview

– 50S ribosomal inhibitor.   IV or PO (but PO form
Antibiotics Class Overview ... due to potential toxicity ... Gray baby syndrome ... #Pharmacology #Antibiotics ... #Review #Overview
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
/ hypoxemia -> focus ... before beginning treatment ... - Compartment syndrome ... - HIV/HAART medications ... lactate and can act
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
Bipolar Disorder Toxicity ... and diuretics all ... Lithium is a medication ... maintenance agent for treatment ... #Pharmacology #
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment ... Myelodysplastic syndromes ... influence outcomes and treatment ... risk of organ toxicity